Effect of continuous melatonin infusions on steady-state plasma melatonin levels in rats under near physiological conditions.
It was the aim of this study to measure the actual amount of melatonin required for elevating the circulating hormone from low daytime levels to the 10-fold higher nocturnal steady-state concentrations in rats. For this purpose, escalating doses of melatonin were continuously infused into the right jugular vein and blood samples were repeatedly drawn from the left jugular vein for a period of 2 hr in freely moving catheterized rats. In order to achieve an about 10-fold elevation of the plasma melatonin concentration, 500 ng melatonin/hr had to be infused, i.e., about 300 times the normal nocturnal melatonin content of the pineal. Infusions of up to 61 ng melatonin/hr (equivalent to the melatonin content of 40 pineals at darkness) failed to cause a significant rise of the low daytime steady-state concentrations in the blood. If the dose of 500 ng melatonin/h was infused at night, a less-pronounced rise of the blood levels was observed, as compared to that caused by the infusion of the same dose during daytime. No differences were found in the rate of metabolism between daytime and nighttime. The results of this study indicate 1) that the low basal concentrations of melatonin in the blood are not affected by an increased melatonin supply up to a certain critical threshold, 2) that the rat pineal gland would have to release all its melatonin content almost every 10 sec in order to sustain the elevated steady-state level of melatonin in the circulation during the dark period, and 3) that significant day/night differences exist in the disposition of circulating melatonin if administered in near physiological amounts and under near physiological conditions.
Huether
G
G
Psychiatrische Klinik der Universität Göttingen, Germany. ghuethe@gwdg.de
Messner
M
M
Rodenbeck
A
A
Hardeland
R
R
D000818:Animals; D002940:Circadian Rhythm; D007262:Infusions, Intravenous; D008297:Male; D008550:Melatonin / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D011863:Radioimmunoassay; D051381:Rats; D017208:Rats, Wistar / Q000378:metabolism*
D008550:Melatonin